Allen RR - Search Results

1

Multiple sclerosis prevalence in the United States commercially insured population.

Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Dilokthornsakul P, et al. Among authors: allen rr. Neurology. 2016 Mar 15;86(11):1014-21. doi: 10.1212/WNL.0000000000002469. Epub 2016 Feb 17. Neurology. 2016. PMID: 26888980 Free PMC article.

2

Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study.

McQueen RB, Livingston T, Vollmer T, Corboy J, Buckley B, Allen RR, Nair K, Campbell JD. McQueen RB, et al. Among authors: allen rr. J Manag Care Spec Pharm. 2015 Mar;21(3):210-8b. doi: 10.18553/jmcp.2015.21.3.210. J Manag Care Spec Pharm. 2015. PMID: 25726030 Free PMC article.

3

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ. Morrato EH, et al. Clin Ther. 2007 Jan;29(1):183-95. doi: 10.1016/j.clinthera.2007.01.002. Clin Ther. 2007. PMID: 17379060

4

Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis.

Nair KV, Corboy J, Kahler K, Allen RR, Ghushcyan V, McQueen RB, Bainbridge J, Dastani H, Mody-Patel N. Nair KV, et al. Among authors: allen rr. Expert Rev Neurother. 2011 Jun;11(6):787-98. doi: 10.1586/ern.11.67. Expert Rev Neurother. 2011. PMID: 21651327

5

Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data.

Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Morrato EH, et al. Among authors: allen rr. J Clin Psychiatry. 2008 Feb;69(2):316-22. doi: 10.4088/jcp.v69n0219. J Clin Psychiatry. 2008. PMID: 18251625

6

Monitoring suicidal patients in primary care using electronic health records.

Anderson HD, Pace WD, Brandt E, Nielsen RD, Allen RR, Libby AM, West DR, Valuck RJ. Anderson HD, et al. Among authors: allen rr. J Am Board Fam Med. 2015 Jan-Feb;28(1):65-71. doi: 10.3122/jabfm.2015.01.140181. J Am Board Fam Med. 2015. PMID: 25567824 Free article.

7

Claims analysis of hypertension occurrence, severity changes and patterns of antihypertensive use in cancer patients receiving vascular endothelial growth factor inhibitors.

Thompson LA, Saseen JJ, O'Bryant CL, Allen RR, Nair KV. Thompson LA, et al. Among authors: allen rr. J Oncol Pharm Pract. 2015 Aug;21(4):258-67. doi: 10.1177/1078155214530177. Epub 2014 Apr 11. J Oncol Pharm Pract. 2015. PMID: 24727344

8

How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs.

Valuck RJ, Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R; Medicaid Pharmacotherapy Research Consortium. Valuck RJ, et al. Curr Med Res Opin. 2007 Oct;23(10):2567-76. doi: 10.1185/030079907X233214. Curr Med Res Opin. 2007. PMID: 17848204

9

Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users.

Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Morrato EH, et al. Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):66-75. doi: 10.1002/pds.2062. Epub 2010 Nov 15. Pharmacoepidemiol Drug Saf. 2011. PMID: 21182154

10

Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers.

Nair KV, Park J, Wolfe P, Saseen JJ, Allen RR, Ganguly R. Nair KV, et al. Among authors: allen rr. J Occup Environ Med. 2009 May;51(5):594-603. doi: 10.1097/JOM.0b013e31819b8c1c. J Occup Environ Med. 2009. PMID: 19369897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters